FDA Recalls Acetaminophen Injection Due to Labeling Mix-up
Hikma Pharmaceuticals is recalling Acetaminophen Injection because bags of Dexmedetomidine HCl were found packaged inside Acetaminophen-labeled overWraps. The error could result in patients receiving the wrong intravenous medication.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class I recall, which mandates a minimum severity rating of 4. The labeling error—placing a different injectable drug in Acetaminophen-labeled packaging—creates significant risk of medication administration errors that could cause serious harm.
Plain-English summary
Hikma Pharmaceuticals USA Inc. is recalling Acetaminophen Injection, 1,000 mg per 100 mL, for intravenous use. The recall affects 31,400 bags (lot #24070381, expiration 09/30/2025) distributed to Ohio and Puerto Rico.
The recall was initiated due to a labeling error. At least one bag of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection was discovered packaged inside an overwrap labeled as Acetaminophen Injection. Since Dexmedetomidine is a completely different medication than Acetaminophen, administering the wrong product could result in serious patient harm.
Healthcare facilities that received product from the affected lot should immediately remove all units from use and quarantine them. Verify the lot number and expiration date to identify affected inventory. Contact Hikma Pharmaceuticals or your supplier if you have questions about whether your supply is affected. Patients who may have received medication from this lot should contact their healthcare provider immediately.
The recalled product
- Product
- ACETAMINOPHEN (ACETAMINOPHEN)
- Brand
- ACETAMINOPHEN
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Category
- Drug — Injectable / Intravenous
- Hazard
- mis-labeling
- medication-error
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #24070381
- Exp. 09/30/2025
Distribution
Distributed in 2 states:
- OH
- PR
Related recalls
Same brand · ACETAMINOPHEN
- ModerateFDA recalls Baxter acetaminophen injection for discoloration defect
FDA (Drugs) · 2025-09-03
- SevereAcetaminophen tablets incorrectly labeled with aspirin drug facts information
FDA (Drugs) · 2024-08-14
- ModerateExtra Strength Acetaminophen 500mg Tablets Recalled for Discoloration
FDA (Drugs) · 2024-07-03
- HighAcetaminophen Injection Recalled for Temperature Storage Abuse Nationwide
FDA (Drugs) · 2022-08-24
- ModerateAcetaminophen Oral Suspension Recalled Due to Contaminated Raw Ingredient
FDA (Drugs) · 2021-11-17
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27